Strategy & Management

Magazine articles on business strategy, management and leadership.

Old Articles: <Older 7631-7640 Newer>

The Motley Fool May 2, 2006 Tom Taulli	Yahoo! Talks Tech The search giant's newest offering, Yahoo! Tech, lures gadget lovers. With Yahoo! earning most of its money from advertising, tech product companies are likely to get a lot of traction on the site.
The Motley Fool May 2, 2006 Alyce Lomax	Insane CEO Pay As investors, it can often be sobering to take a hard look at management compensation information in a company's proxy materials. Should shareholders say enough's enough?
The Motley Fool May 2, 2006 Brian Gorman	Ford Faces Reality The automaker's reality TV car design show idea is well worth a try.
The Motley Fool May 2, 2006 Tom Taulli	WebEx Making Money on Demand Microsoft is gunning for the on demand collaboration software provider WebEx, which so far has been able to build a defensible business. WebEx needs to take this threat very seriously.
The Motley Fool May 2, 2006 Rich Duprey	Roper Romping Through Acquisitions This engineered industrial products company grows by buying rivals. Although its acquisition strategy might be working for it right now, investors might want to be cautious about how well it can continue to assimilate new businesses.
The Motley Fool May 2, 2006 Rick Aristotle Munarriz	The Shanda Shuffle The online gaming giant in China has a little executive shuffle in store this summer. What does it mean for investors?
The Motley Fool May 2, 2006 Rick Aristotle Munarriz	Movie Tie-Ins Sting Like a Bee Starbucks and McDonald's are serving up celluloid turkeys. Box office disappointments force one to question whether the movie world's move to warm up to chains with wide reaches is ineffective or, even worse, counterproductive.
The Motley Fool May 2, 2006 Rick Aristotle Munarriz	Netflix's $5.99 Flix Trick Netflix gets aggressive in selling used DVDs.
Pharmaceutical Executive May 1, 2006 Joanna Breitstein	Pharm Exec Q&A: Japanese Wedding Here, Daiichi Sankyo Pharma's John Alexander talks about the goals of its recent merger, the progress thus far, and shares insight into the development plans for its anti-platelet agent prasugrel.
Pharmaceutical Executive May 1, 2006 Pasternak et al.	Vaccines: Market on the Rebound The vaccine business was safely inoculated against higher profits. But innovative therapies and looser government controls may spark an outbreak. Are pharmaceuticals ready for this opportunity?
<Older 7631-7640 Newer> Return to current articles.